skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Uses of monoclonal antibody 8H9

Abstract

This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides different uses of the monoclonal antibody 8H9 or its derivative.

Inventors:
Issue Date:
Research Org.:
Sloan-Kettering Institute for Cancer Research (New York, NY)
Sponsoring Org.:
USDOE
OSTI Identifier:
1083806
Patent Number(s):
8,414,892
Application Number:
12/721,798
Assignee:
Sloan-Kettering Institute for Cancer Research (New York, NY)
DOE Contract Number:  
FG02-93ER61658
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Cheung, Nai-Kong V. Uses of monoclonal antibody 8H9. United States: N. p., 2013. Web.
Cheung, Nai-Kong V. Uses of monoclonal antibody 8H9. United States.
Cheung, Nai-Kong V. Tue . "Uses of monoclonal antibody 8H9". United States. https://www.osti.gov/servlets/purl/1083806.
@article{osti_1083806,
title = {Uses of monoclonal antibody 8H9},
author = {Cheung, Nai-Kong V.},
abstractNote = {This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides different uses of the monoclonal antibody 8H9 or its derivative.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2013},
month = {4}
}

Patent:

Save / Share: